VXRT
Vaxart, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 1 ▼ Vaxart reported a significant Q4 2025 EPS miss of -$0.10 versus the…
- May 19 Vaxart filed preliminary proxy materials and issued an open letter t…
- May 22 ▲ 1 insider buy $6.5K at $0.6530
- Nov 5 ▲ Earnings: VXRT Q3 2026 Earnings: EPS $-0.07 (+62.8% vs est)
Signal stack
Where each data set points today.
- InsidersBULLISH
1 insider bought $6.5K at an average $0.6530. No open-market sales. Price is 45% below their cost.
- InstitutionsMIXED
Q3 2025: 1 added (0 new), 0 trimmed or exited.
- Short sellersSTEADY
Short interest +0.5% to 2.42M shares. 4.0 days to cover.
- TrendDOWNTREND
18% below its 50-day average.
Who's buying
13F· Q3 2025| Fund | Move | Value |
|---|---|---|
| SIMPLEX TRADING, LLC | ADD | $6.0K |
| UBS Group AG | ADD | $373.2K |
| Squarepoint Ops LLC | TRIM | $202.0K |
| ROYAL BANK OF CANADA | DOUBLED | $101.0K |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | $48.3K |
| GOLDMAN SACHS GROUP INC | ADD | $44.0K |
| Sequoia Financial Advisors, LLC | TRIM | $16.7K |
| HighTower Advisors, LLC | TRIM | $7.7K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Mar 2025Price is below the lowest target. Median implies +1011%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Mar 27, 2025 | B. Riley Securities MAINTAIN | Buy |
| Aug 15, 2024 | Oppenheimer INITIATE | Outperform |
| Jan 31, 2024 | B. Riley Securities UPGRADE | Buy |
| Sep 7, 2023 | Cantor Fitzgerald REITERATE | Overweight |
| Aug 7, 2023 | Cantor Fitzgerald MAINTAIN | Overweight |
| Dec 19, 2022 | B. Riley Securities MAINTAIN | Neutral |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Bono Raquel C. Director Oct 16, 2026 | AWARD | 78,800 sh |
Bono Raquel C. Director Oct 16, 2026 | AWARD | 157,400 sh |
HERON ELAINE J Director Jul 16, 2026 | AWARD | 78,700 sh |
BREITMEYER JAMES B Director Jul 16, 2026 | AWARD | 8,315 sh |
HERON ELAINE J Director Jul 16, 2026 | AWARD | 39,400 sh |
Wheadon David E. Director Jul 16, 2026 | AWARD | 39,400 sh |
Watson W. Mark Director Jul 16, 2026 | AWARD | 78,700 sh |
Watson W. Mark Director Jul 16, 2026 | AWARD | 39,400 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.19 | -$0.19–-$0.19 | No data | $41.6M |
| Next Q | None | None | No data | $0.00 |
| Current FY | -$0.68 | -$0.68–-$0.68 | -1233.3% | $118.6M |
| Next FY | -$1.03 | -$1.03–-$1.03 | -51.5% | $4.7M |
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
21 filings · 2 press releases · 1 bullish · 3 bearish · 2 mixed · 15 neutral- BEARISH 8-KNov 5, 2026
Vaxart reported Q3 2026 revenue of $10.6M, down 85% from $72.4M a year ago, and a net loss of…
The revenue collapse and widening loss reflect the lumpy nature of BARDA contract revenue recognition. The key catalyst is the Phase 2b COVID-19 data readout now pushed to mid-2027, extending the…
- NEUTRAL 8-KOct 19, 2026
Vaxart appointed retired Vice Admiral Raquel C. Bono, M.D., to its Board of Directors effective…
The appointment signals continued implementation of the July 2026 cooperation agreement with activist stockholders, but no new financial or operational catalysts are provided. Monitor for any future…
- NEUTRAL 8-KJul 28, 2026
Vaxart filed an 8-K reporting a routine reorganization of its Board committees, appointing Kevin…
This is a routine governance filing with no trading implications. Monitor next quarterly report for pipeline updates and cash runway, which are the primary value drivers for VXRT.
- NEUTRAL 8-KJul 7, 2026
Vaxart reported topline 12-month safety data from the 400-participant sentinel safety cohort of…
Safety data is clean but the sentinel cohort is too small for efficacy conclusions. The main cohort readout in 2027 is the key catalyst. Monitor for any early efficacy signals or regulatory…
All VXRT filing & press-release reports (23)
- 8-K reportNov 5, 2026
- 8-K reportOct 19, 2026
- 8-K reportJul 28, 2026
- 8-K reportJul 7, 2026
- DEFA14A reportJul 6, 2026
- DEFA14A reportJul 2, 2026
- 8-K reportJul 2, 2026
- 8-K reportJun 26, 2026
- DEFA14A reportJun 26, 2026
- DEFA14A reportJun 26, 2026
- DEFA14A reportJun 16, 2026
- DEFA14A reportJun 8, 2026
- DEFA14A reportJun 8, 2026
- DEFA14A reportJun 1, 2026
- DEFA14A reportMay 20, 2026
- DEFA14A reportMay 20, 2026
- PREC14A reportMay 19, 2026
- DEFA14A reportMay 19, 2026
- PRESS-RELEASE reportMay 1, 2026
- 8-K reportApr 21, 2026
- PRESS-RELEASE reportApr 17, 2026
- 8-K reportApr 17, 2026
- PRESS-RELEASE reportMar 3, 2026